Stifel Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Stifel Financial’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.18M	Buy	2,343 +7	+0.3%	+$3.7K	﹤0.01%	2447
2026 Q2	$1.25M	Sell	2,336 -5	-0.2%	-$2.56K	﹤0.01%	2405
2026 Q1	$1.23M	Buy	2,341 +14	+0.6%	+$6.69K	﹤0.01%	2310
2025 Q4	$1.36M	Sell	2,327 -282	-11%	-$144K	﹤0.01%	2237
2025 Q3	$1.2M	Sell	2,609 -565	-18%	-$211K	﹤0.01%	2278
2025 Q2	$961K	Buy	3,174 +77	+2%	+$22.9K	﹤0.01%	2359
2025 Q1	$1.03M	Buy	3,097 +499	+19%	+$164K	﹤0.01%	2214
2024 Q4	$802K	Sell	2,598 -107	-4%	-$30.1K	﹤0.01%	2394
2024 Q3	$574K	Sell	2,705 -263	-9%	-$67.3K	﹤0.01%	2590
2024 Q2	$832K	Buy	+2,968	New	+$707K	﹤0.01%	2296

Other funds holding MDGL

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Stifel Financial's MDGL Position: Q3 2026 in Review

Stifel Financial increased its Madrigal Pharmaceuticals (MDGL) stake by 0.3% in Q3 2026, buying an estimated $3.7K and bringing the position to 2,343 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Stifel Financial first reported a position in MDGL in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.36M in Q4 2025. 283 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

Stifel Financial held 2,343 shares of Madrigal Pharmaceuticals worth $1.18M as of Q3 2026.
Stifel Financial bought 7 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $3.7K.
Madrigal Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #2447 holding.
Stifel Financial first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
Stifel Financial's Madrigal Pharmaceuticals position peaked at $1.36M in Q4 2025.
283 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.